Diffuse Large B-Cell Lymphoma (DLBCL), Nos
1 clinical trials · Condition
◉ Watch Diffuse Large B-Cell Lymphoma (DLBCL), Nos
| Record | Firm | Date |
|---|---|---|
| Assessment of Survival and Autonomy With Rituximab Plus Chemotherapy or Rituximab Plus Lenalidomide for Elderly Patients With Relapsed Diffuse Large B-cell Lymphoma (NCT04113226) | Centre Hospitalier Universitaire, Amiens | 2021-11-09 |
Track Diffuse Large B-Cell Lymphoma (DLBCL), Nos automatically
Every clearance here is in the API, with alerts when new ones post.